1. Home
  2. VKTX vs PATK Comparison

VKTX vs PATK Comparison

Compare VKTX & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • PATK
  • Stock Information
  • Founded
  • VKTX 2012
  • PATK 1959
  • Country
  • VKTX United States
  • PATK United States
  • Employees
  • VKTX N/A
  • PATK N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • VKTX Health Care
  • PATK Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • PATK Nasdaq
  • Market Cap
  • VKTX 3.0B
  • PATK 3.5B
  • IPO Year
  • VKTX 2015
  • PATK N/A
  • Fundamental
  • Price
  • VKTX $33.65
  • PATK $98.86
  • Analyst Decision
  • VKTX Strong Buy
  • PATK Buy
  • Analyst Count
  • VKTX 12
  • PATK 10
  • Target Price
  • VKTX $86.42
  • PATK $104.50
  • AVG Volume (30 Days)
  • VKTX 5.3M
  • PATK 255.5K
  • Earning Date
  • VKTX 10-22-2025
  • PATK 10-30-2025
  • Dividend Yield
  • VKTX N/A
  • PATK 1.60%
  • EPS Growth
  • VKTX N/A
  • PATK N/A
  • EPS
  • VKTX N/A
  • PATK 3.69
  • Revenue
  • VKTX N/A
  • PATK $3,816,541,000.00
  • Revenue This Year
  • VKTX N/A
  • PATK $3.72
  • Revenue Next Year
  • VKTX N/A
  • PATK $5.73
  • P/E Ratio
  • VKTX N/A
  • PATK $27.00
  • Revenue Growth
  • VKTX N/A
  • PATK 6.09
  • 52 Week Low
  • VKTX $18.92
  • PATK $72.99
  • 52 Week High
  • VKTX $81.73
  • PATK $116.78
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 62.67
  • PATK 36.44
  • Support Level
  • VKTX $25.04
  • PATK $98.81
  • Resistance Level
  • VKTX $32.85
  • PATK $106.60
  • Average True Range (ATR)
  • VKTX 1.49
  • PATK 2.72
  • MACD
  • VKTX 1.01
  • PATK -0.71
  • Stochastic Oscillator
  • VKTX 88.54
  • PATK 13.81

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: